Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities

Cancer Research

Volumn 70, Issue 15, 2010, Pages 6109-6113

  Jha, Priyanka ^a   Golovko, Daniel ^a   Bains, Sukhmine ^a   Hostetter, Daniel ^b   Meier, Reinhard ^a   Wendland, Michael F ^a   Daldrup Link, Heike E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; INDIUM 111; METHYL IODIDE; SUPERPARAMAGNETIC IRON OXIDE;

BIOLUMINESCENCE; CANCER IMMUNOTHERAPY; CELL LABELING; FIBROSARCOMA; FLUORESCENCE IMAGING; HUMAN; MELANOMA; NATURAL KILLER CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; DIAGNOSTIC IMAGING; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, NATURAL; MONITORING, IMMUNOLOGIC; NEOPLASMS;

EID: 77955366838     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3774     Document Type: Review

References (21)

1. Srivastava S, Lundqvist A, Childs RW. Natural killer cell immunotherapy for cancer: a new hope. Cytotherapy 2008;10:775-83.
2. Miller JS. Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential? Cytotherapy 2009;11:259-60.
3. Meller B, Frohn C, Brand JM, et al. Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma. Eur J Nucl Med Mol Imaging 2004;31:403-7.
4. Brand JM, Meller B, Von Hof K, et al. Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma. Stem Cells Dev 2004;13:307-14. (Pubitemid 38738372)
5. Matera L, Galetto A, Bello M, et al. In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma. J Transl Med 2006;4:49.
6. de Vries IJ, Lesterhuis WJ, Barentsz JO, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005;23:1407-13.
7. Daldrup-Link HE, Meier R, Rudelius M, et al. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 2005;15:4-13.
8. Edinger M, Cao YA, Verneris MR, Bachmann MH, Contag CH, Negrin RS. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 2003;101:640-8. (Pubitemid 36077588)
9. Tavri S, Jha P, Meier R, et al. Optical imaging of cellular immunotherapy against prostate cancer. Mol Imaging 2009;8:15-26.
10. 18F]FDG- labeled natural killer cells to HER2/neu-positive tumors. Nucl Med Biol 2008;35:579-88.
11. Melder RJ, Brownell AL, Shoup TM, Brownell GL, Jain RK. Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors. Cancer Res 1993;53:5867-71.
12. Meier R, Boddington S, Krug C, et al. Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System. J Transl Med 2008;6:73.
13. Chaise C, Itti E, Petegnief Y, et al. [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model. Cancer Immunol Immunother 2007;56:1163-71.
14. Sutton EJ, Henning TD, Pichler BJ, Bremer C, Daldrup-Link HE. Cell tracking with optical imaging. Eur Radiol 2008;18:2021-32.
15. Poellinger A, Martin JC, Ponder SL, et al. Near-infrared laser computed tomography of the breast first clinical experience. Acad Radiol 2008;15:1545-53.
16. Wu YJ, Muldoon LL, Varallyay C, Markwardt S, Jones RE, Neuwelt EA. In vivo leukocyte labeling with intravenous ferumoxides/ protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging. Am J Physiol Cell Physiol 2007;293:C1698-708.
17. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480-7.
18. Henning TD, Wendland MF, Golovko D, et al. Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells. Magn Reson Med 2009;62:325-32.
19. Munnink T, Nagengast W, Brouwers A, et al. Molecular imaging of breast cancer. Breast 2009;18 [Suppl 3]:S66-73.
20. Lim YT, Cho MY, Noh YW, Chung JW, Chung BH. Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy. Nanotechnology 2009;20:475102.
21. Rzigalinski BA, Strobl JS. Cadmium-containing nanoparticles: Perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol 2009;238:280-8.